For more information, contact Abbott.
For more information, contact Abbott.
| PRODUCT NAME | UNIT SIZE | ORDER NUMBER | GTIN |
|---|
The assay is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of initiation of therapy and for use as an aid in monitoring viral response to antiviral treatment as measured by changes in plasma or whole blood DNA levels.
This assay is not intended to be used as a screening test for CMV or as a diagnostic test to confirm the presence of CMV infection.
To learn more about Abbott RealTime CMV please visit: https://www.molecular.abbott/int/en/products/infectious-disease/realtime-cmv
| ABBOTT REALTIME CMV | |
| Limit of Detection | 31.2 IU/mL (20 copies/mL) plasma sample 62.4 IU/mL (40 copies/mL) whole blood sample |
| Linear range | Plasma samples: 31.2 IU/mL to 156 million IU/mL Whole blood samples: 62.4 IU/mL to 156 million IU/mL |
| Internal Control | Non-competitive pumpkin DNA, added to lysis buffer during extraction |
| Calibration | External two point calibration |
| Standardization | 1st WHO International Standard for Human Cytomegalovirus for Nucleic Acid Amplification Techniques (NIBSC 09/162) |
| Specimen type | Plasma (EDTA) and whole blood (EDTA) |
| Input volume | 0.5 mL plasma, 0.3 mL whole blood |
| Sample preparation | m2000sp - plasma & whole blood m24 sp and manual - plasma |
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.